Treatment of primary cranial dystonia (Meige's syndrome) with clozapine [3]

Journal of Clinical Psychiatry

Volumn 61, Issue 12, 2000, Pages 949-

  Sieche, A ^a   Giedke, H ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BOTULINUM TOXIN; CLOZAPINE; NEUROLEPTIC AGENT; TETRABENAZINE; TRIHEXYPHENIDYL;

ADULT; AGRANULOCYTOSIS; ANHEDONIA; BLEPHAROSPASM; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DISEASE CLASSIFICATION; DRUG BLOOD LEVEL; DYSTONIA; FEMALE; HUMAN; INSOMNIA; LETTER; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSOCIAL WITHDRAWAL; SUICIDE ATTEMPT; TIC; TREATMENT OUTCOME;

EID: 0034534594     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n1210c     Document Type: Letter

References (12)

1. The pathophysiology of primary dystonia
2. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): Clinical aspects
3. Classification and investigation of dystonia
4. Successful treatment of tardive dystonia with clozapine
5. Clozapine and tardive dystonia
6. The effects of clozapine on tardive dyskinesia
7. Successful treatment of tardive dystonia with clozapine and clonazepam
8. Use of clozapine in tardive dystonia
9. Tardive Meige syndrome responsive to clozapine
10. Blepharospasm and orofacial-cervical dystonia: Clinical and pharmacological findings in 100 patients
11. Spontaneous involuntary disorders of movement
12. Clinical and demographic features of Meige's syndrome